Publications by authors named "Tyler Kokjohn"

Claim this Profile
A
APP/Aβ structural diversity and Alzheimer's disease pathogenesis.
Alex E Roher, Tyler A Kokjohn, Steven G Clarke, Michael R Sierks, Chera L Maarouf

Neurochem Int· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
Alex E Roher, Chera L Maarouf, Tyler A Kokjohn

J Alzheimers Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab.
Alex E Roher, Chera L Maarouf, Tyler A Kokjohn, Christine Belden, Geidy Serrano

Am J Neurodegener Dis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease.
Chera L Maarouf, Tyler A Kokjohn, Douglas G Walker, Charisse M Whiteside, Walter M Kalback

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat.
Alex E Roher, Chera L Maarouf, Tyler A Kokjohn, Charisse M Whiteside, Walter M Kalback

Am J Neurodegener Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis.
Chera L Maarouf, Tyler A Kokjohn, Charisse M Whiteside, MiMi P Macias, Walter M Kalback

Biochem Insights· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy.
Alex E Roher, David H Cribbs, Ronald C Kim, Chera L Maarouf, Charisse M Whiteside, Tyler A Kokjohn

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.
Alex E Roher, Chera L Maarouf, Michael Malek-Ahmadi, Jeffrey Wilson, Tyler A Kokjohn

Am J Neurodegener Dis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurochemical profile of dementia pugilistica.
Tyler A Kokjohn, Chera L Maarouf, Ian D Daugs, Jesse M Hunter, Charisse M Whiteside

J Neurotrauma· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral blood flow in Alzheimer's disease.
Alex E Roher, Josef P Debbins, Michael Malek-Ahmadi, Kewei Chen, James G Pipe, Tyler A Kokjohn

Vasc Health Risk Manag· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.
Chera L Maarouf, Thomas G Beach, Charles H Adler, Michael Malek-Ahmadi, Tyler A Kokjohn

Biomark Insights· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease.
Jesse M Hunter, Jason Kwan, Michael Malek-Ahmadi, Chera L Maarouf, Tyler A Kokjohn

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations.
Eduardo M Castaño, Chera L Maarouf, Terence Wu, Maria Celeste Leal, Charisse M Whiteside, Tyler A Kokjohn

Neurochem Int· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?
Tyler A Kokjohn, Chera L Maarouf, Alex E Roher

Alzheimers Dement· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.
Chera L Maarouf, Thomas G Beach, Charles H Adler, Holly A Shill, Marwan N Sabbagh, Tyler A Kokjohn

Neurol Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease.
Jesse M Hunter, William J Bowers, Chera L Maarouf, Michael A Mastrangelo, Ian D Daugs, Tyler A Kokjohn

J Alzheimers Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging.
Chera L Maarouf, Ian D Daugs, Tyler A Kokjohn, Douglas G Walker, Jesse M Hunter

PLoS One· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets.
Tyler A Kokjohn, Gregory D Van Vickle, Chera L Maarouf, Walter M Kalback, Jesse M Hunter

Biochim Biophys Acta· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient.
Alex E Roher, Chera L Maarouf, Ian D Daugs, Tyler A Kokjohn, Jesse M Hunter

J Alzheimers Dis· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease.
Alex E Roher, Zsolt Garami, Suzanne L Tyas, Chera L Maarouf, Tyler A Kokjohn

Alzheimers Dement· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.
Alex E Roher, Suzanne L Tyas, Chera L Maarouf, Ian D Daugs, Tyler A Kokjohn

Alzheimers Dement· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biochemical aftermath of anti-amyloid immunotherapy.
Chera L Maarouf, Ian D Daugs, Tyler A Kokjohn, Walter M Kalback, R Lyle Patton

Mol Neurodegener· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Alzheimer disease have altered transmitral flow: echocardiographic analysis of the vortex formation time.
Marek Belohlavek, Panupong Jiamsripong, Anna M Calleja, Eileen M McMahon, Chera L Maarouf, Tyler A Kokjohn

J Ultrasound Med· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
Alex E Roher, Tyler A Kokjohn

Alzheimers Dement· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects.
Chera L Maarouf, Tracy M Andacht, Tyler A Kokjohn, Eduardo M Castaño, Lucia I Sue

Curr Alzheimer Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis